Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.627
+0.027 (4.50%)
Apr 29, 2026, 11:51 AM EDT - Market open
Cytosorbents Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 6.25 | 3.28 | 14.13 | 22.14 | 52.14 | Upgrade
|
| Cash & Short-Term Investments | 6.25 | 3.28 | 14.13 | 22.14 | 52.14 | Upgrade
|
| Cash Growth | 90.52% | -76.79% | -36.19% | -57.53% | -27.00% | Upgrade
|
| Receivables | 7.55 | 7.32 | 6.06 | 5.66 | 4.52 | Upgrade
|
| Inventory | 5.28 | 2.73 | 3.38 | 3.46 | 4.77 | Upgrade
|
| Prepaid Expenses | 1.55 | 3.27 | 1.83 | 2.49 | 2.87 | Upgrade
|
| Restricted Cash | - | 5 | - | - | - | Upgrade
|
| Total Current Assets | 20.63 | 21.6 | 25.4 | 33.76 | 64.3 | Upgrade
|
| Property, Plant & Equipment | 18.75 | 20.51 | 22.12 | 23.35 | 18.57 | Upgrade
|
| Other Intangible Assets | 3.23 | 3.72 | 3.91 | 4.39 | 4.7 | Upgrade
|
| Other Long-Term Assets | 1.58 | 1.53 | 1.54 | 1.73 | 1.94 | Upgrade
|
| Total Assets | 44.18 | 47.37 | 52.96 | 63.23 | 89.52 | Upgrade
|
| Accounts Payable | 2.87 | 3.34 | 3.8 | 1.66 | 2.81 | Upgrade
|
| Accrued Expenses | 5.06 | 4.71 | 4.99 | 6.43 | 8.37 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 2.5 | - | - | Upgrade
|
| Current Portion of Leases | 0.54 | 0.45 | 0.37 | 0.11 | 0.57 | Upgrade
|
| Current Unearned Revenue | 0.18 | 0.6 | 1.38 | 1.52 | 1.95 | Upgrade
|
| Other Current Liabilities | 1.06 | 0.72 | 0.99 | - | - | Upgrade
|
| Total Current Liabilities | 9.71 | 9.83 | 14.04 | 9.71 | 13.69 | Upgrade
|
| Long-Term Debt | 16.67 | 14 | 2.54 | 5 | - | Upgrade
|
| Long-Term Leases | 11.9 | 12.44 | 12.9 | 13.14 | 13.25 | Upgrade
|
| Total Liabilities | 38.28 | 36.27 | 29.48 | 27.86 | 26.94 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 321.02 | 310.81 | 306.19 | 287 | 283.19 | Upgrade
|
| Retained Earnings | -312.21 | -304.01 | -283.29 | -254 | -221.19 | Upgrade
|
| Comprehensive Income & Other | -2.98 | 4.25 | 0.53 | 2.33 | 0.53 | Upgrade
|
| Shareholders' Equity | 5.9 | 11.11 | 23.48 | 35.37 | 62.58 | Upgrade
|
| Total Liabilities & Equity | 44.18 | 47.37 | 52.96 | 63.23 | 89.52 | Upgrade
|
| Total Debt | 29.11 | 26.89 | 18.31 | 18.25 | 13.82 | Upgrade
|
| Net Cash (Debt) | -22.86 | -23.61 | -4.18 | 3.89 | 38.32 | Upgrade
|
| Net Cash Growth | - | - | - | -89.84% | -45.57% | Upgrade
|
| Net Cash Per Share | -0.37 | -0.43 | -0.09 | 0.09 | 0.88 | Upgrade
|
| Filing Date Shares Outstanding | 62.7 | 62.5 | 54.29 | 43.66 | 43.51 | Upgrade
|
| Total Common Shares Outstanding | 62.8 | 54.83 | 54.24 | 43.64 | 43.48 | Upgrade
|
| Working Capital | 10.93 | 11.78 | 11.36 | 24.05 | 50.61 | Upgrade
|
| Book Value Per Share | 0.09 | 0.20 | 0.43 | 0.81 | 1.44 | Upgrade
|
| Tangible Book Value | 2.68 | 7.39 | 19.57 | 30.98 | 57.88 | Upgrade
|
| Tangible Book Value Per Share | 0.04 | 0.13 | 0.36 | 0.71 | 1.33 | Upgrade
|
| Machinery | 6.66 | 6.95 | 6.87 | 6.44 | 7.29 | Upgrade
|
| Leasehold Improvements | 6.31 | 6.28 | 6.22 | 6.2 | 2.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.